Drug information for MUCOSIL-10

Form	Dosage	Status	Therapeutic Equivalence	Active Ingred	Ref.	Sponsor	Document
SOLUTION; INHALATION, ORAL	10%	Discontinued		ACETYLCYSTEINE	Acetylcysteine	DEY	70575

Drug Adverse Effects information for MUCOSIL-10

Role code	Indications	Reaction	# Reports
C	ANAPLASTIC ASTROCYTOMA	ANAEMIA	1
C	ANAPLASTIC ASTROCYTOMA	CEREBRAL ATROPHY	1
C	ANAPLASTIC ASTROCYTOMA	DEVICE RELATED INFECTION	1
C	ANAPLASTIC ASTROCYTOMA	HYPOALBUMINAEMIA	1
C	ANAPLASTIC ASTROCYTOMA	OLIGURIA	1
C	ANAPLASTIC ASTROCYTOMA	OROPHARYNGEAL CANDIDIASIS	1
C	ANAPLASTIC ASTROCYTOMA	THROMBOCYTOPENIA	1
C	ASTHMA	DELIRIUM	1
C	ASTHMA	PYREXIA	1
C	ASTHMA	SLEEP TERROR	2
C	CANCER PAIN	WHITE BLOOD CELL COUNT DECREASED	1
C	CASTLEMAN'S DISEASE	BLOOD BILIRUBIN INCREASED	2
C	CASTLEMAN'S DISEASE	BLOOD PHOSPHORUS DECREASED	2
C	CASTLEMAN'S DISEASE	CONSTIPATION	2
C	CASTLEMAN'S DISEASE	DERMAL CYST	2
C	CASTLEMAN'S DISEASE	DIARRHOEA	2
C	CASTLEMAN'S DISEASE	HAEMATURIA	2
C	CASTLEMAN'S DISEASE	HERPES ZOSTER	2
C	CASTLEMAN'S DISEASE	HYPERURICAEMIA	2
C	CASTLEMAN'S DISEASE	LYMPHOCYTE MORPHOLOGY ABNORMAL	2
C	CASTLEMAN'S DISEASE	NEOPLASM OF ORBIT	2
C	CASTLEMAN'S DISEASE	NEUTROPHIL COUNT DECREASED	2
C	CASTLEMAN'S DISEASE	OEDEMA PERIPHERAL	2
C	CASTLEMAN'S DISEASE	PAIN IN EXTREMITY	2
C	CASTLEMAN'S DISEASE	PNEUMONIA	2
C	CASTLEMAN'S DISEASE	PROTEIN URINE PRESENT	2
C	CASTLEMAN'S DISEASE	RASH	2
C	CASTLEMAN'S DISEASE	STOMATITIS	2
C	CASTLEMAN'S DISEASE	UPPER RESPIRATORY TRACT INFLAMMATION	2
C	CEREBRAL ATROPHY	ANAEMIA	4
C	CEREBRAL ATROPHY	CEREBRAL ATROPHY	4
C	CEREBRAL ATROPHY	DEVICE RELATED INFECTION	4
C	CEREBRAL ATROPHY	HYPOALBUMINAEMIA	4
C	CEREBRAL ATROPHY	OLIGURIA	4
C	CEREBRAL ATROPHY	OROPHARYNGEAL CANDIDIASIS	4
C	CEREBRAL ATROPHY	THROMBOCYTOPENIA	4
C	COLORECTAL CANCER	HEPATIC FUNCTION ABNORMAL	1
C	EPILEPSY	HYPOKALAEMIA	2
C	INFLUENZA	DELIRIUM	2
C	INFLUENZA	SLEEP TERROR	2
C	LUNG NEOPLASM MALIGNANT	AGRANULOCYTOSIS	1
C	LUNG NEOPLASM MALIGNANT	OROPHARYNGEAL PAIN	1
C	LUNG NEOPLASM MALIGNANT	PYREXIA	1
C	LUNG NEOPLASM MALIGNANT	SEPSIS	1
C	MUSCLE SPASTICITY	IMPLANT SITE EFFUSION	1
C	MUSCLE SPASTICITY	IMPLANT SITE OEDEMA	1
C	NEURALGIA	COGNITIVE DISORDER	3
C	NEURALGIA	MALAISE	3
C	NEURALGIA	SPEECH DISORDER	3
C	PNEUMONIA	AGRANULOCYTOSIS	2
C	PNEUMONIA	OROPHARYNGEAL PAIN	2
C	PNEUMONIA	PYREXIA	2
C	PNEUMONIA	SEPSIS	2
C	PREGNANCY	ASTHMA	8
C	PREGNANCY	CAESAREAN SECTION	8
C	PREGNANCY	CEREBRAL VENTRICLE DILATATION	8
C	PREGNANCY	HYDROCEPHALUS	8
C	PREGNANCY	LOW BIRTH WEIGHT BABY	8
C	PREGNANCY	MENINGOCELE	8
C	PREGNANCY	PATERNAL DRUGS AFFECTING FOETUS	8
C	PRODUCT USED FOR UNKNOWN INDICATION	AGRANULOCYTOSIS	2
C	PRODUCT USED FOR UNKNOWN INDICATION	OROPHARYNGEAL PAIN	2
C	PRODUCT USED FOR UNKNOWN INDICATION	PYREXIA	2
C	PRODUCT USED FOR UNKNOWN INDICATION	SEPSIS	2
C	PRODUCT USED FOR UNKNOWN INDICATION	WHITE BLOOD CELL COUNT DECREASED	1
C	RENAL FAILURE	AGRANULOCYTOSIS	2
C	RENAL FAILURE	OROPHARYNGEAL PAIN	2
C	RENAL FAILURE	PYREXIA	2
C	RENAL FAILURE	SEPSIS	2

Ads by Google